Here are the facts that activist critics of Pfizer CEO Albert Bourla are missing, according to a Yale analysis
Some misleading narratives about Bourla’s leadership that have been put forward have been distinctly unfair,' write Jeff ...
Pfizer Inc. (NYSE:PFE) is largely controlled by institutional shareholders who own 67% of the company
Every investor in Pfizer Inc. ( NYSE:PFE) should be aware of the most powerful shareholder groups. We can see that ...
MoneyWeek1d
Pfizer shares rise as US investor takes $1 billion stake
Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic ...
TipRanks on MSN5d
Does Pfizer’s (PFE) 5.9% Yield Represent Rewarding Income or A Risky Bet?
Pfizer ($PFE) has long been a staple in the portfolios of income-oriented investors, especially those drawn to its consistent ...
Pfizer wins FDA approval for hemophilia B drug that will be first once-weekly treatment
The new drug would allow patients to produce the needed clotting protein for an extended period, reducing the need for ...
Pfizer: A 6% Yielding Ultra SWAN Bargain With Upside Potential
Pfizer (PFE) stock may present opportunities for patient investors. Read how this biotech giant may deliver long-term ...
Pfizer CEO’s job is at risk. A shot of discipline could help.
As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.
Is one COVID vaccine better than the others? An infectious disease doctor breaks it down
The FDA recently approved the updated mRNA Pfizer and Moderna boosters, as well as the updated Novavax COVID vaccine, to ...
EconoTimes1d
Activist Investor Starboard Value Presses Pfizer's Board Amid Corporate Tensions
The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard ...
SCHD's 3 Best Dividend Buys (And 5 You Should Avoid)
ETFs such as The Schwab US Dividend ETF can be useful, but a 'DIY' approach can help you outperform. Here are 3 of the best ...
BioSpace2d
Pfizer’s TALZENNA® in Combination with XTANDI® Prolongs Overall Survival in Phase 3 TALAPRO-2 Trial
(NYSE: PFE) today announced positive topline results from the final prespecified overall survival (OS) analysis of the ...
3 Magnificent Dividend Stocks to Buy in October
Three Motley Fool contributors believe they have identified magnificent dividend stocks to buy in October -- and all of them are drugmakers. Here's why they picked AbbVie (NYSE: ABBV), Amgen (NASDAQ: ...